Previously, we reported a genome-wide scan for nicotine dependence (ND) in the African American (AA) sample of the Mid-South Tobacco Family (MSTF) cohort. In this study, we conducted a genome-wide scan in 629 individuals representing 200 nuclear families of European American (EA) origin of the MSTF cohort with the goals of identifying vulnerability loci for ND in the EAs and determining converging regions across the ethnic groups. We examined 385 autosomal microsatellite markers for ND, which was assessed by smoking quantity (SQ), the Heaviness of Smoking Index (HSI) and the Fagerströ m test for ND (FTND). After performing linkage analyses using various methods implemented in the GENEHUNTER and SAGE programs, we found eight regions on chromosomes 2, 4, 9-12, 17 and 18 that met the criteria for suggestive linkage to at least one ND measure in the EA sample. Of these, the region on chromosome 4 at 43 cM showed suggestive linkage to indexed SQ, the HSI and the FTND, and the region on chromosome 9 at 24 cM showed suggestive linkage to the HSI and the FTND. To increase detection power, we analyzed a combined AA and EA sample using age, gender and ethnicity as covariates and found that the region on chromosome 12 near marker D12S372 showed significant linkage to SQ. Additionally, we found six regions on chromosomes 9-11, 13 and 18 that showed suggestive linkage to at least one ND measure in the combined sample. When we compared the linkage peaks detected for ND among the two samples and a combined sample, we found that four regions on chromosomes 9 (two regions), 11 and 18 overlapped. On the other hand, we identified five regions on chromosomes 2, 4, 10, 12 and 17 that showed linkage to ND only in the EA sample, and two regions on chromosomes 10 and 13 that showed linkage to ND only in the AA sample. For those linkages identified in only one sample, we found that the combined analysis of AA plus EA samples actually decreased the linkage signal. This indicates that some chromosomal regions may be more homogenous than others across the ethnic samples. All regions except for the one on chromosome 12 have been detected at nominally significant levels in other studies, providing independent replication of ND loci in different populations.
Introduction
Tobacco smoking is a major world health problem, as nearly one-third of the global adult population smokes tobacco products. 1 Over the last decade, many large-sample twin studies in the United States and other countries have yielded results supporting the overall conclusion that genetics contributes to the risk of becoming a regular smoker. [2] [3] [4] [5] [6] A meta-analysis of the genetic parameter estimates for nicotine dependence (ND) based on 17 twin studies determined that the weighted mean polygenic heritability for ND is 0.59 in male and 0.46 in female smokers, with an average of 0.56 for all smokers. 6 Thus, identifying the genes predisposing to ND and understanding their molecular mechanisms are vital to prevention and treatment.
We are aware of a dozen of published genomewide linkage studies for smoking behavior. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Although numerous regions have been identified as susceptibility loci for ND, most have not been replicated except for those on chromosomes 9q22 and 11p11, which have received broad support. 8, 19 Given most participants in these studies were of European origin (except one based on a Native American Mission Indian cohort 16 ), it is of interest to determine whether converging regions exist across different ethnic groups. Recently, we reported the first genome-wide linkage study on ND in an AfricanAmerican (AA) sample, in which significant linkage to chromosome 10 and suggestive linkage to chromosomes 9, 11 and 13 were identified. 20 The present study describes the results of our genome-wide linkage scan for a sample of European Americans (EA). The participants of EA origin were recruited simultaneously with the participants of AA origin reported in the previous study, 20 using the same enrollment criteria, and recruiting from the same geographic regions during the same period of time, removing potentially important sources of sample bias. Thus, we report our linkage analysis results for the EA sample, with an emphasis on identifying converging regions across these two ethnic samples.
Materials and methods

Participants
The participants were drawn from the Mid-South Tobacco Family (MSTF) cohort, recruited from Tennessee, Mississippi and Arkansas during 1999-2004. Proband smokers were required to be at least 21 years of age, to have smoked for at least the last 5 years, and to have consumed an average of 20 cigarettes per day for the last 12 months. For the purpose of this paper, smoking participants were assessed using the Fagerströ m test for Nicotine Dependence (FTND). 21 Once a proband and a full sib who was also nicotine dependent (for most of our families) were identified, additional siblings and parents were recruited whenever possible, regardless of smoking status. If biological parents were not available, we attempted to recruit at least three full sibs per family. Extensive clinical data have been collected from all participants, including demographics, medical history, smoking history, smoking experience, ND and personality characteristics, as assessed by various questionnaires (for a detailed description of questionnaires used in the study, visit the website for the Center for Genetics Studies at National Institute on Drug Abuse of NIH; http://zork.wustl.edu/nida).
A total of 629 participants comprising 200 EA families were included in the study. The families ranged in size from 2 to 6 with an average of 3.1670.71 (s.d.). Among these families, 77% had at least one biological parent recruited, 63% had two full sibs and 29% had three or more full sibs. Descriptive statistics regarding demographic and clinical characteristics are presented in Table 1 . All participants provided informed consent and this study was approved by all involved institutional review boards.
Phenotype assessment
Many measures have been used to assess ND, including the number of cigarettes smoked per day, 22, 23 current tobacco use status 24 and the FTND. 25, 26 Although these measures are not identical, they are highly correlated. 4, 6 In the present study, the ND of each smoker was ascertained by three measures commonly used in the literature: smoking quantity (SQ: defined as the number of cigarettes smoked per day), the Heaviness of Smoking Index (HSI: 0-6 scale), 27 which includes SQ and smoking urgency (that is, how soon after waking up the subject smokes the first cigarette) and the FTND score (0-10 scale). 21 The correlation coefficients across these measures ranged from 0.88 to 0.94 in our dataset. As reported previously, 14, 20 we transformed non-zero SQ values to a natural log-scale or an indexed SQ, in which 28 The errors (a total of 8559 Mendelian inconsistencies, approximately 2.13% error rate) identified in PedCheck were assumed to have occurred in the genotyping process, and the associated markers were set to missing for the corresponding members. In addition, we used all markers to check pedigree errors by means of the RelCheck program. 29 To avoid bias, individuals with a false genetic relationship were excluded from further analysis.
Statistical and linkage analysis
Two linkage analysis programs (SIBPAL in SAGE v. 5.1 and GENEHUNTER v. 2.1) were used. For the GENEHUNTER program, we used the expectation maximization Haseman-Elston (HE) regression, variance component and non-parametric method to analyze all ND measures. Multipoint methods were used for estimating identity by descent (IBD) sharing needed for calculating these statistics. Other conditions for running the programs employed the relevant program defaults. For SAGE, the GENIBD program was first used to calculate multipoint IBD allele sharing distributions separately for each ethnicity, based on genotypes from all family members. SIBPAL, a model-free SAGE linkage program, was then used to perform the linkage analysis based on all possible sib pairs. Evidence for linkage was assessed via HE regression with dependent variable options W3 and W4 which transform the sib-pair's trait values to weighted combinations of the squared trait difference and squared mean corrected trait sum; the former adjusts for the non-independence of sib pairs while the latter adjusts for the non-independence of sib pairs and the non-independence of squared trait sums and differences. 30 Otherwise, default options were used for all parameters in the trait regression method. Sex and age were included as covariates for all analyses in the EA sample, and sex, age and ethnicity were included as covariates for the combined sample.
To determine empirical estimates of genome-wide significance level, we performed linkage analyses on 1000 replicate permutations using an approach described previously, 15 with both family structure and IBD structure kept intact. The empirical significance level of an observed log of the odds ratio (LOD) score or P-value for an ND measure of interest was then estimated by counting the proportion of genome scans containing one or more peaks of that value. The significant linkage threshold used in the study was defined as the LOD score or P-value occurring in 50 of the 1000 permutations, corresponding to a probability of 0.05 in a genome scan. 31 The S-Plus (v. 6.1) and SAS (v. 8.2) packages were used to prepare the required data format for the programs and to summarize the data generated from the linkage analysis programs.
To determine the presence of potential heterogeneity in the pooled sample around the linkage peaks, we (1) combined the EA and AA samples for a pooled analysis and (2) performed Fisher's test 32 to combine the individual P-value from the individual AA and EA samples. There are two types of heterogeneity possible in the combined sample: existence or nonexistence of a segregating locus, and varying magnitude of the linkage signal arising from different allele frequencies and penetrances across the ethnic groups. Either can cause a decrease in the linkage signal for the combined sample as compared with that from a single ethnic sample. The latter type of heterogeneity would not be expected to lead to a decrease in linkage signal based on Fisher's test. Thus, to determine the kind of potential heterogeneity and gain better insight into analysis strategy, we compared the significances from the pooled sample analysis and Fisher's test.
Results
Linkage analysis in the EA sample Multipoint linkage analyses revealed suggestive evidence of linkage to different ND measures on eight chromosomes (Table 2 ) based on the genome-wide significance threshold of Nyholt. 33 Although we have performed linkage analysis for SQ, indexed SQ, logtransformed SQ, HSI and FTND in our genotyping data, only the regions that showed suggestive linkage to an ND measure are reported. Except for the regions on chromosomes 10 and 12 that were detected by the non-parametric and variance component methods of GENEHUNTER, respectively, all regions were detected by the SIBPAL program of SAGE. Furthermore, the linkage regions on chromosomes 4 and 9 were detected for multiple ND measures, providing further support for linkage of these regions to ND. As shown in Figure 1 , the region on chromosome 4 showed suggestive linkage to indexed SQ, HSI and FTND, and the region on chromosome 9 did so for HSI and FTND.
Linkage analysis for the combined sample To maximize the power of our linkage analysis, we combined our data from the EA sample with that of AA sample. This method has been well accepted and used in the literature because (1) many linkage studies have been conducted on participants with different ethnic origins and (2) the participants of both groups in the MSTF cohort were recruited simultaneously using identical clinical recruitment criteria. Because the linkage results for the AA sample were reported previously, 20 no further discussion of these results is provided here. Table 3 summarizes the linkage regions that revealed significant or suggestive linkage to ND measures in the combined sample. We identified six regions on five chromosomes that showed suggestive linkage to at least one ND measure, and one region on chromosome 12 that showed significant linkage to SQ. Of these vulnerability loci for ND, three were Figure 1 Multipoint linkage analysis from the SIBPAL program of SAGE for indexed SQ, SQ, HSI and log-transformed SQ on chromosomes 4 and 9 in the EA sample. Genetic distance (in cM) is plotted on the x axis against -log 10 (P-value) from SIBPAL. The horizontal line in each graph corresponds to the threshold for suggestive linkage. 33 Because the empirical P-value cutoffs for different phenotypes in the EA sample were close to their corresponding theoretical one, we did not show the empirical thresholds in this or any other figure in the interest of a clearer presentation. EA, European American; HSI, heaviness of smoking index; SQ, smoking quantity.
linked to FTND score, five to SQ or transformed SQ and one to HSI. Interestingly, two regions near markers C9S1879 at 24 cM and D9S1825 at 134 cM from the p terminus were identified on chromosome 9, with the first region linked to both FTND and HSI and the second to FTND (Figure 2 ). The regions on chromosomes 12 and 13 were revealed based on the variance component method of GENEHUNTER; all other regions were identified using SIBPAL.
Converging linkage regions among the EA, AA and combined samples Following identification of linked regions to different ND measures for the two ethnic samples of the MSTF cohort, we determined which regions are linked to ND in both samples and which are linked in only one sample. Further, we evaluated whether increasing the sample size by combining the ethnic samples would improve the linkage signal and provide more supportive evidence relative to linkage results obtained from either individual ethnic sample. In an effort to simplify the presentation of each figure, we selected the linkage results for the ND measure that yielded the most convincing statistical evidence of linkage from each sample. Any region demonstrating a significant or suggestive linkage to one ND measure in any sample was included in our comparison.
As shown in Figure 3 , nine chromosomes showed significant or suggestive linkage to at least one ND measure in the AA, EA and/or combined samples. Of these linkages, we found that four regions on chromosomes 9 (two regions), 11 and 18 were linked to ND in both the EA and AA samples; an additional four regions on chromosomes 2, 4, 12 and 17 were linked in the EA sample; and two regions on chromosomes 10 and 13 were linked in the AA sample. The comparison between the linkage results from the combined sample and Fisher's test of 
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Indexed SQ HSI FTND SQ Log-transformed SQ Figure 2 Linkage analysis results of various ND measures on chromosomes 9 and 18 in the combined sample. Genetic distance (in cM) is plotted on the x axis against -log 10 (P-value) from SIBPAL. The horizontal line in each graph corresponds to the threshold for suggestive linkage. 33 
Discussion
This study provides evidence for suggestive linkage of eight chromosomal regions to at least one ND measure in the EA sample. Of these, the region on chromosome 4 between D4S403 and D4S2632 was linked to indexed SQ, HSI and FTND, and the region on chromosome 9 between D9S2169 and D9S925 was linked to HSI and FTND. In addition, we performed linkage analyses on a combined sample of EA participants from the current study and the AA participants employed in a previous study 20 with the intention of maximizing our power to detect linkage by increasing the sample size from 629 to 1890. In this combined sample, the region on chromosome 12 near D12S372 showed significant linkage to SQ with an LOD score of 4.435, and six regions on chromosomes 9 (at 24 and 134 cM), 10 (at 96 cM), 11 (at 9 cM), 13 (at 42 cM) and 18 (at 71 cM for FTND and 81 cM for indexed SQ) showed suggestive linkage to at least one ND measure. The regions on chromosomes 9, 11, 12 and 18 were detected in both the EA and the combined sample.
To gain a better understanding of converging linkages among the EA, AA and combined samples −log 10 P −log 10 P −log 10 P −log 10 P −log 10 P −log 10 P −log 10 P −log 10 P −log To simplify our comparisons, only the linkage analysis results from one ND measure (except for chromosome 9) were included in each sample. For those linkage results obtained from GENEHUNTER, which includes EA/SQ and AA/SQ on chromosome 10, AA/indexed SQ on chromosome 11, EA/SQ and AA/SQ on chromosome 12, combined/SQ on chromosome 13 and AA/indexed SQ on chromosome 17, we first converted their LOD to a P-value before logarithmic transformation. The horizontal line in each graph corresponds to the threshold for suggestive linkage. 33 AA, African American; EA, European American; LOD, log of the odds ratio; ND, nicotine dependence; SQ, smoking quantity.
of the MSTF cohort, we compared the linkage results from these three samples for all chromosomes that showed any suggestive or significant linkage to an ND measure in any sample. Given that the purpose of our comparison was to identify converging linkage regions, we used a relatively relaxed criterion for determining overlap among the samples. In other words, we considered the region overlapped as long as the linkage intervals of the samples shared a region across the chromosome of interest. Our comparison indicated that the regions on chromosomes 9, 11 and 18 were either linked or possibly linked to ND in all three samples (Figure 3 ; the maximum P-value equals 0.00128 among the three samples for the ND measures under consideration; the empirical genome-wide P-value for suggestive linkage to SQ is 0.002158). On the other hand, the regions on chromosomes 2, 4, 10, 12 and 17 showed linkage to ND with the maximum P-value being 0.00122 for SQ in the EA sample, which is less than the genome-wide empirical threshold of 0.002158 for suggestive linkage, while the regions on chromosomes 10 and 13 were linked to ND in the AA sample (see our recent report 20 ). Thus, we tentatively conclude that only one of the two samples contributed to some of these linkages in the combined sample.
Of the eight linkage regions revealed in the EA sample, most have received independent support from other cohorts, although the peaks identified among these studies are not identical even if there was considerable overlap (for reviews, see references vink et al., 8 Li et al., 19 Uhl 34 ). For example, a linkage of ND to chromosomes 9, 11 and 17 was reported in the Framingham Heart Study (FHS) sample, 14,15 of smoking to chromosome 11 in a family study of panic disorder 13 and in a nuclear family sample who were cocaine or opioid dependent, 18 of alcohol dependence to chromosomes 9 and 11 in an American Indian population, 35 and of polysubstance abuse to chromosomes 4, 9 and 11. 36, 37 Using the Collaborative Study on the Genetics of Alcoholism data (COGA), Bergen et al. 10 reported a linkage to ever-never smoking on chromosome 2, and Duggirala et al. 11 revealed a linkage to the number of packs smoked per year on chromosome 4; both of these regions slightly overlap with regions identified in this study. The positive region for ND on chromosome 2 has been linked to alcohol dependence in the COGA sample 38, 39 and in the Oregon Smoking Families study. 40 The linkage region for ND on chromosome 4 detected in the EA sample of the MSTF cohort has also been linked to alcohol dependence in three independent samples 35, 38, 40, 41 and to polysubstance abuse. 36, 37 Moreover, two recent large-scale association studies also provide partial support to some of our linkage findings. 42, 43 For example, two susceptibility genes Neurexin 1 and dopamine b-hydroxylase, as well as SNP rs4859365 were identified in the two studies, and are located in our linkage regions on chromosomes 2, 4 and 9, respectively. 42, 43 In the combined sample, our linkage results revealed one significant linkage to ND on chromosome 12 with an LOD of 4.435 and six suggestive linkages to ND on chromosomes 9-11, 13 and 18. Of these seven genomic regions, ND was linked to four regions on chromosomes 9 (at 24 cM), 11, 12 and 18 in the EA sample, and five regions on chromosomes 9 (at 134 cM), 10, 11, 13 and 18 in the AA sample. 20 Previous linkage and/or association studies have provided independent convergence with the abovementioned linkage findings. For example, the linkage region on chromosome 10 is overlapped with the regions identified by Gelernter et al. 18 for ND and with one of the 16 reported candidate regions that may harbor vulnerability genes for polysubstance abuse. 36, 37 Moreover, the gene (CTNNA3) coding for aT-catenin identified by Bierut et al. 42 is located in our detected linkage region on chromosome 10 reported in the present as well as one of our previous studies. 20 Interestingly, we identified two suggestive linkages on chromosome 9 in the combined sample, with the first, between D9S2169 and D9S1121, being stronger in the EA sample and the second, between D9S930 and D9S2157, being stronger in the AA sample. Previously, we have linked both regions on chromosome 9 to ND in the FHS sample.
14, 15 The first of these linked regions has previously been reported to be a susceptibility locus for alcohol dependence 35 and polysubstance abuse. 37 The second region has received considerable independent replication for smoking dependence 7, 12, 18, 44 and alcohol consumption. 45 The strong statistical support found here for linkage of ND to chromosome 12 is novel and significant. To our knowledge, this region has never been reported as a susceptibility locus for ND or other substance abuse. Using the genome-wide significance threshold of Lander and Kruglyak, 31 this region showed suggestive linkage to SQ (LOD = 2.49) in the EA sample and significant linkage to SQ (LOD = 4.435) in the combined sample. On the basis of these results from the EA and combined samples, we conducted a linkage analysis within the region on chromosome 12 for the AA sample, which revealed a weak linkage signal as well (see Figure 3 ). This suggests that the region may harbor a susceptibility locus for ND for both ethnic groups, with smaller effects likely for AA smokers. The findings of the human genome sequence suggest that there are approximately 300 genes within this region. Of these, the genes encoding ionotropic Nmethyl D-aspartate glutamate receptor subunit 2B (GRIN2B), neurotrophin 3 (NTF3), GABA-A receptor-associated protein-like protein 1 (GABARAPL1) and a cluster of subunits for a taste receptor represent plausible candidates for a future association study in view of their biological function(s) and the biochemical pathways involved in drug addiction. [46] [47] [48] [49] [50] Although several association studies have been conducted to investigate the association of NTF3 and GRIN2B with schizophrenia and alcohol dependence, the results have been inconclusive. [51] [52] [53] [54] Regarding potential candidate genes from other regions, we will not discuss these in the present report because (1) they have been reported previously for possible association with nicotine and/or alcohol dependence in independent sample; (2) potential candidate genes for a few chromosomal regions were discussed in our recent report based on the AA sample; 20 and/or (3) a limited number of candidate genes are obvious on the basis of their functionality unless we are able to demonstrate their association experimentally, a consideration which is well beyond the scope of this report.
Our study has several strengths. The first is that our sample size is relatively large and thus provided greater power to detect potential linkage with ND. Furthermore, our samples represent two major ethnic groups in the United States, allowing for an examination of genetic differences in ND between these populations. Moreover, the three ND measures (SQ, HSI and FTND) analyzed herein are commonly employed in both genetic and applied clinical research of tobacco smoking and thus are readily available for cross-study replication by other investigators. 55 Although the three measures are highly interrelated, they are not identical, 56 such that linkage detected for more than one ND measure provides greater confidence in the validity of our results.
Because of these aforementioned strengths, we have learned much from this study. One of the most important lessons addresses a better linkage analysis strategy. Although it has been common to perform genome-wide linkage studies on samples consisting of participants of different origins, this might not represent an optimal approach unless we can make an assumption regarding the homogeneity of the sample. In heterogeneous samples, the linkage results could be confusing or misleading. Our comparison of linkage results from the EA, AA and combined samples showed that some linkage peaks were detectable in only one ethnic sample, implying that combining subjects of differing ethnic origins to increase sample size would not necessarily improve the statistical power to detect linkage. In retrospect, this factor might be partly responsible for the low replication rate across multiple studies for many complex traits, including ND. In addition, our comparison of linkage results across the samples implies that homogeneity may be region or chromosome dependent, with some regions more homogeneous than others across the whole genome. This may explain why the large size of the combined sample improved the statistical power to detect linkage in some genomic regions but not others. Finally, the use of alternative statistical strategies, such as employing Fisher's test that combines individual P-values from independent samples, can deliver supplemental information to the linkage analysis on a mixed sample. This may partly remedy loss of power due to the heterogeneity of the pooled sample, as we identified decreased P-values on chromosomes 9, 13 and 18 with Fisher's test.
In addition, as stated above, our linkage analyses were primarily focused on the convergence of the linkage regions across two ethnic populations and thus only uncorrected P-values were shown. Because the three ND measures are highly intercorrelated (0.89-0.97 for AAs, and 0.91-0.97 for EAs), and there is no accepted methodology available to correct for interrelated multiple testing, we did not perform Bonferroni corrections for the three phenotypes. Thus, some caution should be exercised when interpreting our findings.
In conclusion, we provide evidence for suggestive linkage of ND to chromosomes 2, 4, 9-12, 17 and 18 in our EA sample. Further, we identified one region on chromosome 12 that showed significant linkage to ND and five regions on chromosomes 9, 10, 11, 13 and 18 that showed suggestive linkage to ND in our combined sample. By comparing the linkage results identified from the two samples and their combination, we found four overlapping regions on chromosomes 9 (two regions), 11 and 18. We further identified five regions on chromosomes 2, 4, 10, 12 and 17 that showed linkage to ND only in the EA sample and two regions on chromosomes 10 and 13 that showed linkage to ND only in the AA sample. Except for the region on chromosome 12 that represents a novel locus for ND, all the remaining positive regions have been linked to smoking, alcohol and/or polysubstance abuse in other samples, thus providing independent replication of the regions reported in this study. This is the first study to report a linkage of the region on chromosome 12 to ND, which contains several plausible candidate genes. We conclude that these regions represent excellent candidate loci to harbor allelic variants that alter vulnerability to ND. Further analysis of these regions by fine mapping and/or association analysis is thus warranted.
